Patent · US Active

Compositions comprising a modified GIcNAc-1-phosphotransferase and methods of use thereof

US11732249B2 · kind B2 · utility

0Cited by

1References

8Claims

0Family size

Assignee

Washington University · US

Inventors

Stuart Kornfeld · Saint Louis, US
Lin Liu · Gainesville, US
Wang Lee · Chesterfield, US
Balraj Doray · Chesterfield, US

Key dates

Filing date	Dec 17, 2020
Grant date	Aug 22, 2023
Priority date	—
Expiry date	Jul 26, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y207/08017
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The disclosure provides a modified UDP-GlcNAc:Lysosomal Enzyme GlcNAc phosphotransferase with enhanced ability to phosphorylate lysosomal enzymes and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.